Both in Pharmaceuticals
Harrow vs Janux Therapeutics
Over the past year HROW returned −26.5% and JANX returned −41.7%; their daily moves had a correlation of 0.11.
HROW −26.5% JANX −41.7%Growth of $1, one year, split-adjusted
| Metric | HROW | JANX |
|---|---|---|
| Price | $26.04 | $16.06 |
| Market cap | $976.2M | $981.9M |
| Today | −9.43% | −11.66% |
| 1 month | −15.0% | −10.4% |
| 6 months | −33.3% | +10.5% |
| Year to date | −46.9% | +16.4% |
| 1 year | −26.3% | −40.5% |
| Revenue growth (YoY) | +10.9% | — |
| Gross margin | 71.3% | 100.0% |
| Net margin | −24.4% | −214.0% |
| P/E (TTM) | — | — |
| Price / sales | 3.5× | 40.9× |
| Net cash | -$208.5M | $970.9M |
| Dividend yield | — | — |
| Volatility (60d) | 44.2% | 54.2% |
| Short % of float | 24.3% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).